GENERAL COMMENTS
Thank you for the opportunity to review the protocol, which I read with interest. Conducting quality research on cranioplasty materials is of paramount importance, because complication rates for this routine neurosurgical procedure are very bleak all over the world. The choice of cranioplasty material has received substantial interest as a potential modifiable risk factor. Despite the common prevalence of the procedure in the neurosurgical practice, there is still no clear consensus regarding the most appropriate material to be used.
My comments on the protocol:
Line 95: The term "Neurosurgical function" is vague and needs to be defined Line 113: Are the authors planning to include all patients not depending on the background diagnosis, e.g. TBI, malignant MCA infarction, SAH, infiltrative tumor, intracranial infection? Please define.
Line 119: Exclusion criteria: Because the aim is to study the performance of the implant materials, patient-dependent risk factors should be minimized. I suggest adding at least 1) smoking, 2) diabetes, 3) radiation therapy, 4) suspicion of hydrocephalus, 5) hypersensitivity to metals (ref: Sun, Y. et al (2018) . Association between metal hypersensitivity and implant failure in patients who underwent titanium cranioplasty. Journal of Neurosurgery. doi:10.3171/2018.1.JNS171804)
Line 150: It appears that the titanium implants will be onlay implants and the PEEK implants will be inlay implants. The authors must acknowledge that inlay implants may have higher risk for postoperative hematoma due to the related surgical technique.
Line 154: I consider bandaging highly controversial approach to treat cerebral swelling as it may lead to ischemia. I suggest omitting.
Line 159: Again, if the authors want to purely assess the performance of the materials, the patient-dependent risk factors should be minimized. In case of a dural tear, I suggest patient exclusion.
Line 178: I suggest adding superficial surgical site infection, which does not result in implant removal.
Line 184: TCDS suffers from variability in assessment between the clinicians. Uniform training should be provided to all investigating clinicians and the number of investigators should be minimized.
Line 224: Not all patients subjected to cranioplasty are capable of understanding the individual risks related to the implant materials due to the severe background diagnosis that has lead to bony defect in the skull (severe TBI, SAH, MCA infarct etc). The informed consent as presented is inadequate. If the patient's cognition is impaired, the patient's next of kin should be carefully informed.
Overall, I consider this project very important and support its implementation. Unfortunately, the design of the study gives the impression that researchers have not spent sufficient time to consider how to minimize patient-related risk factors in order to evaluate the survival of the implant material as purely as possible. My comments on the protocol:
REVIEWER
1.Line 95: The term "Neurosurgical function" is vague and needs to be defined
Response:
We changed the "Neurosurgical function" to neurological and cognitive outcome, the neurological outcome was assessed by GCS, GOS scores and cognitive outcome was assessed by
Mini-Mental State Examination (MMSE). The motor function was evaluated by Oxford grading system.
The correction was shown in Line 97.
2.Line 113:
Are the authors planning to include all patients not depending on the background diagnosis, e.g. TBI, malignant MCA infarction, SAH, infiltrative tumor, intracranial infection? Please define.
Response:
We intend to include all patients not depending on the background diagnosis (severe TBI, ischemic stroke, hemorrhagic stroke, infiltrative tumor, etc.), the correction was shown in Line 117-118. 4.Line 150: It appears that the titanium implants will be onlay implants and the PEEK implants will be inlay implants. The authors must acknowledge that inlay implants may have higher risk for postoperative hematoma due to the related surgical technique.
Response: The surgical procedure was almost the same between the two groups except that the exposed area was larger for titanium cranioplasty due to the characteristic of the implant. Moreover, a retrospective research shows that inlay implants do not have higher risk for postoperative hematoma.
The authors propose an open-label, multicenter, prospective randomized trial to compare patient specific CAD/CAM titanium mesh vs. PEEK for cranioplasty. Despite a lack of high-level evidence for clinical equipoise or superiority regarding these materials, the motivation for this study remains unclear.
The industry involvement is not adequately addressed. Considering previous studies, the results are likely to show a high complication rate associated with cranioplasty in general. To date, there is no highlevel evidence to favor alloplastic materials over autologous bone. Thus, there is a high probability for this study to replicate redundant results.
Response: Cranioplasty, a common surgical procedure used to restore cranial integrity, has underwent many revolutions to find ideal materials to improve outcome. Autologous bone was regarded as gold standard in skull reconstruction; however, the bone flap resorption was a common complication and in some severe cases, necessitating reoperation and replacement with alloplastic materials. A randomized controlled trial comparing autologous bone with titanium cranioplasty, and 7 out of 31 patients had complete resorption of autologous bone and were deemed as failure (Honeybul S et al., 2017) .
Therefore, it is necessary to explore the optimal alloplastic materials especially for patients with bone flap resorption or infection. Titanium mesh was a popular material and Polyetheretherketone (PEEK) implants are gaining popularity for cranial reconstruction. Although some retrospective researches have compared the outcome of titanium mesh and PEEK cranioplasty and make some preliminary analysis, there were differences in terms of success and complication rates (Zhang et al., 2019) . Moreover, there is no high-level evidence regarding these materials, thus we believe this study is of great clinical significance. This is the motivation for this study. The introduction part included relevant information and the correction was shown in Line 70-71.
Previous researches have studied the complications rates associated with cranioplasty in general, this study will not only study the complications rates but the relationship to timing. Moreover, the subgaleal effusion following cranioplasty was a common but less a studied complication. Some researchers speculated it was because of delayed type allergic reactions after cranioplasty (Qiu et al., 2019 ) and we will do further study to investigate the mechanisms. The discussion part included some discussions and the correction was shown in Line 262-263.
Generally speaking, this study entails more than repeating the same task, we also raise some innovative questions and do further treatment.
